AUSTRALIAN JOURNAL OF BIOMEDICAL RESEARCH
Review Article

Biofilms in Resource-Limited Settings: Challenges, Opportunities, and Innovative Solutions in Nigeria

Australian Journal of Biomedical Research, 1(2), 2025, aubm008, https://doi.org/10.63946/aubiomed/17419
Publication date: Nov 13, 2025
Full Text (PDF)

ABSTRACT

Microbial biofilms represent a growing yet often overlooked public health concern, particularly in resource-limited settings where they exacerbate the burden of persistent infections and antimicrobial resistance (AMR). In Nigeria, fragile healthcare infrastructure, poor funding, and a continuous loss of skilled medical professionals compound the difficulty of managing biofilm-associated infections. These microbial communities, embedded in self-produced extracellular matrices, exhibit remarkable resistance to antimicrobials and host immune defenses, leading to chronic and recurrent infections that further strain an already overstretched health system. This review synthesizes evidence published between 2010 and 2025 to examine the burden, challenges, and opportunities surrounding biofilm control in Nigeria. Literature was systematically retrieved from PubMed, Scopus, and Google Scholar, complemented by reports from WHO and the Nigerian Centre for Disease Control. Findings indicate that biofilms not only complicate clinical treatment outcomes but also persist in environmental reservoirs, particularly water systems, serving as hidden amplifiers of resistance and infection transmission. To address these challenges, the review explores low-cost and context-appropriate strategies such as harnessing Nigeria’s biodiversity for the discovery of plant-derived antibiofilm compounds, implementing decentralized engineering solutions for water treatment, and promoting community-based infection prevention initiatives. It further emphasizes the importance of local innovation, interdisciplinary collaboration, and policy support within a One Health framework that integrates human, animal, and environmental health. By spotlighting the Nigerian experience, this review calls for urgent investment and global attention to biofilm-related infections in Low- and Middle-Income Countries (LMICs).

KEYWORDS

Biofilms Antimicrobial Resistance Nigeria One Health LMICs Water Systems Public Health

CITATION (Vancouver)

Abdulgafar AO, Olowookere AK, Ebiala FI, Fatola ME, Tajudeen IO, Fajimi SR, et al. Biofilms in Resource-Limited Settings: Challenges, Opportunities, and Innovative Solutions in Nigeria. Australian Journal of Biomedical Research. 2025;1(2):aubm008. https://doi.org/10.63946/aubiomed/17419
APA
Abdulgafar, A. O., Olowookere, A. K., Ebiala, F. I., Fatola, M. E., Tajudeen, I. O., Fajimi, S. R., & Ifeoma, M. F. (2025). Biofilms in Resource-Limited Settings: Challenges, Opportunities, and Innovative Solutions in Nigeria. Australian Journal of Biomedical Research, 1(2), aubm008. https://doi.org/10.63946/aubiomed/17419
Harvard
Abdulgafar, A. O., Olowookere, A. K., Ebiala, F. I., Fatola, M. E., Tajudeen, I. O., Fajimi, S. R., and Ifeoma, M. F. (2025). Biofilms in Resource-Limited Settings: Challenges, Opportunities, and Innovative Solutions in Nigeria. Australian Journal of Biomedical Research, 1(2), aubm008. https://doi.org/10.63946/aubiomed/17419
AMA
Abdulgafar AO, Olowookere AK, Ebiala FI, et al. Biofilms in Resource-Limited Settings: Challenges, Opportunities, and Innovative Solutions in Nigeria. Australian Journal of Biomedical Research. 2025;1(2), aubm008. https://doi.org/10.63946/aubiomed/17419
Chicago
Abdulgafar, Ahmad Onikoko, Adepeju Kafayat Olowookere, Fortune Itoje Ebiala, Muyiwa Emmanuel Fatola, Idris Olawale Tajudeen, Sefiu Remi Fajimi, and Mazi Faith Ifeoma. "Biofilms in Resource-Limited Settings: Challenges, Opportunities, and Innovative Solutions in Nigeria". Australian Journal of Biomedical Research 2025 1 no. 2 (2025): aubm008. https://doi.org/10.63946/aubiomed/17419
MLA
Abdulgafar, Ahmad Onikoko et al. "Biofilms in Resource-Limited Settings: Challenges, Opportunities, and Innovative Solutions in Nigeria". Australian Journal of Biomedical Research, vol. 1, no. 2, 2025, aubm008. https://doi.org/10.63946/aubiomed/17419

REFERENCES

  1. Montanari E, Bernardo G, Le Noci V, Anselmi M, Pupa SM, Tagliabue E, et al. Biofilm formation by the host microbiota: a protective shield against immunity and its implication in cancer. Mol Cancer. 2025;24(1):148. https://doi.org/10.1186/s12943-025-02348-0
  2. Almatroudi A. Investigating Biofilms: Advanced Methods for Comprehending Microbial Behavior and Antibiotic Resistance. Front Biosci (Landmark Ed). 2024;29:133. https://doi.org/10.31083/j.fbl2904133
  3. Bayatli N, Malkawi A, Malkawi A, Khaled K, Alrabadi N, Collins Ovenseri A, et al. Impact of biofilms on healthcare settings and management strategies. Rev Med Microbiol. 2024. https://doi.org/10.1097/MRM.0000000000000425
  4. Sharma S, Mohler J, Mahajan SD, Schwartz SA, Bruggemann L, Aalinkeel R. Microbial Biofilm: A Review on Formation, Infection, Antibiotic Resistance, Control Measures, and Innovative Treatment. Microorganisms. 2023;11(6):1614. https://doi.org/10.3390/microorganisms11061614
  5. World Health Organization. Nigeria — WHO Data [Country overview]. 2025 [updated 2025/07/18]. Available from: https://data.who.int/countries/566
  6. Jonah JH, Samuel G, Abdullahi MI, Emmanuel EA, Danladi SS, Ekwuluo CE. Nigeria's public health response to disease outbreaks: A review of strengths and weaknesses. J Public Health Afr. 2024;15(1):773. https://doi.org/10.4102/jphia.v15i1.773
  7. Nigeria GML. The State of Healthcare in Nigeria: Challenges and Opportunities. 2025 [updated 2025/07/18]. Available from: https://gml.com.ng/the-state-of-healthcare-in-nigeria-challenges-and-opportunities/
  8. Umar AA, Salihu HM, Azuine RE. Crisis of Brain Drain in Nigeria’s Health Sector: Challenges, Opportunities, and the Path Forward. Int J MCH AIDS. 14:e011. https://doi.org/10.25259/IJMA_11_2025
  9. Ndibuagu EO, Chime OH, Orji CJ, Aneke TJ. Infection Prevention and Control Practices, and Barriers to Compliance among Medical Doctors and Clinical Medical Students, in a State University Teaching Hospital, Southeast Nigeria. J Adv Med Med Res. 2022;34(20):178–90. https://doi.org/10.9734/jammr/2022/v34i2031483
  10. Caleb G, Okon A, Inah A, Olanrewaju O, Achi F, Bisongedam M. Practices of Infection Prevention and Control among Primary Healthcare Workers and Associated Factors: A Cross-Sectional Study. Trends Med Res. 2023;18:24-35. https://doi.org/10.3923/tmr.2023.24.35
  11. Lawal O, Orenolu IO, Ajobiewe MA, Mensah Forson KAA, Agu UF, Fidelix ME, et al. Hospital-Acquired Infections in the Age of Antimicrobial Resistance and Smart Surveillance. Aust J Biomed Res. 2025;1(1):aubm002. https://doi.org/10.63946/aubiomed/16759
  12. Eze P, Aniebo CL, Ilechukwu S, Lawani LO. Understanding Unmet Healthcare Needs in Nigeria: Implications for Universal Health Coverage. Health Serv Insights. 2025;18:11786329251330032. https://doi.org/10.1177/11786329251330032
  13. Abbas S, Khan S, Shah M, Aslam J, Nawaz H, Ilyas N, et al. Public Health Threats Posed by Biofilms and Innovative Strategies for their Control. Discoveries. 2024. https://doi.org/10.15190/d.2024.16
  14. Alabi ED, Rabiu AG, Adesoji AT. A review of antimicrobial resistance challenges in Nigeria: The need for a one health approach. One Health. 2025;20:101053. https://doi.org/10.1016/j.onehlt.2025.101053
  15. Lawal O. Antibiogram and Molecular Characterization of Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae in a Nigerian Teaching Hospital. Microbes Infect Chemother. 2025. https://doi.org/10.54034/mic.e2305
  16. Olalemi A, Akinruli F, Oluwasusi V. Antibiotic Resistance Pattern of Bacteria Isolated from Biofilms in Water from Groundwater Sources in Ado-Ekiti, Nigeria. South Asian J Res Microbiol. 2019:1-9. https://doi.org/10.9734/sajrm/2019/v3i430093
  17. Agbabiaka T, Teslim S, Otuyelu F. Biofilm-forming bacteria and their antibiotic resistance in treated water supplies in Ilorin Metropolis, Nigeria. Ceylon J Sci. 2021;50:199. https://doi.org/10.4038/cjs.v50i2.7883
  18. Yaki LM, Nwabuisi C, Dagang W, Huyop F. Biofilm Associated Uropathogenic Escherichia coli from Catheterised Patients at a Nigerian Hospital. 2024. https://doi.org/10.21203/rs.3.rs-4007279/v1
  19. Umar K, Abdullahi IN, Magashi AM, Kawo AH, Usman Y, El-Fulaty Ahmad A, et al. Prevalence and clonal lineages of biofilm-producing Staphylococcus aureus from clinical samples and healthcare workers at Ahmadu Bello University Teaching Hospital, Nigeria. GMS Hyg Infect Control. 2024;19:Doc49. https://doi.org/10.3205/dgkh000504
  20. Taner F, Baddal B, Theodoridis L, Petrovski S. Biofilm Production in Intensive Care Units: Challenges and Implications. Pathogens. 2024;13(11):954. https://doi.org/10.3390/pathogens13110954
  21. Silva V, Pereira JE, Maltez L, Poeta P, Igrejas G. Influence of Environmental Factors on Biofilm Formation of Staphylococci Isolated from Wastewater and Surface Water. Pathogens. 2022;11(10). https://doi.org/10.3390/pathogens11101069
  22. Nwankwo CE, Osho A, Adewuy A, Otuechere C, Olawoye IB, Fayemi SO, et al. Combating oral biofilms in Nigerian schoolchildren: a synergistic approach using Macrosphyra longistyla extracts and titanium-ferrite nanoparticles. GMS Hyg Infect Control. 2025;20:Doc22. https://doi.org/10.3205/dgkh000551
  23. Mgbodi GO. Inadequate healthcare service administration and management in Nigeria and solutions. 2023. Available from: https://www.researchgate.net/publication/372769855_INADEQUATE_HEALTHCARE_SERVICE_ADMINISTRATION_AND_MANAGEMENT_IN_NIGERIA_AND_SOLUTIONS
  24. Adedokun AI, Gana SE, Adenrele BO. Bacteria biofilms: Navigating the way forward. Microbes Infect Dis. 2023. https://doi.org/10.21608/mid.2023.236659.1621
  25. Muhammad MH, Idris AL, Fan X, Guo Y, Yu Y, Jin X, et al. Beyond Risk: Bacterial Biofilms and Their Regulating Approaches. Front Microbiol. 2020;11. https://doi.org/10.3389/fmicb.2020.00928
  26. Shareef N. Wastewater Treatment by using Biofilm Technologies as a Low-cost Solution for Rural Areas. In: Bui XN, editor. Biomedical Engineering. Cham: Springer International Publishing; 2020. p. 1-13. https://doi.org/10.1007/698_2022_870
  27. Flores-Vargas G, Bergsveinson J, Lawrence JR, Korber DR. Environmental Biofilms as Reservoirs for Antimicrobial Resistance. Front Microbiol. 2021;12. https://doi.org/10.3389/fmicb.2021.766242
  28. Omoya FO, Salami FF, Ajayi KO. Azadirachta indica Leaf Essential Oil as Control of Biofilm-Producing Microorganisms from Hospital Environment Nigeria. SustainE; 2025. Available from: https://sustaine.org/azadirachta-indica-leaf-essential-oil-as-control-of-biofilm-producing-microorganisms-from-hospital-environment/
  29. Oluwole OM. BIOFILM: FORMATION AND NATURAL PRODUCTS' APPROACH TO CONTROL - A REVIEW. Afr J Infect Dis. 2022;16(2 Suppl):59-71. https://doi.org/10.21010/Ajid.v16i2S.7
  30. Ghosh S, Nag M, Lahiri D, Sarkar T, Pati S, Joshi S, et al. New holistic approach for the management of biofilm-associated infections by myco-metabolites. J Basic Microbiol. 2022;62(11):1291-306. https://doi.org/10.1002/jobm.202200047
  31. Srivastava S, Roddam S, Srivastava D, Shehu A, Gogineni KK, Singla R, et al. Exploring Non-antibiotic Interventions for Preventing Urinary Tract Infections During Pregnancy: A Systematic Review. Cureus. 2025;17(10):e93874. https://doi.org/10.7759/cureus.93874
  32. Fleming D, Rumbaugh KP. Approaches to Dispersing Medical Biofilms. Microorganisms. 2017;5(2):15. https://doi.org/10.3390/microorganisms5020015

LICENSE

Creative Commons License
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.